10.6084/m9.figshare.c.3644222_D3.v1 Austin Nuschke Austin Nuschke Melanie Rodrigues Melanie Rodrigues Albin Wells Albin Wells Kyle Sylakowski Kyle Sylakowski Alan Wells Alan Wells Additional file 3: Figure S3. of Mesenchymal stem cells/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvation Springer Nature 2016 Multipotent stem cells Mesenchymal stem cells Glucose metabolism Nutrient starvation Stem cell survival 2016-12-01 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_Figure_S3_of_Mesenchymal_stem_cells_multipotent_stromal_cells_MSCs_are_glycolytic_and_thus_glucose_is_a_limiting_factor_of_in_vitro_models_of_MSC_starvation/4468175 Theoretical interpretation of Seahorse metabolism output. Data on oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) adapted from the Seahorse Bio manual are plotted and outlined to highlight treatment rationale and subsequent interpretation. For OCR (left), basal mitochondrial respiration (A; blue) is disrupted with oligomycin treatment to inhibit ATP synthase and demonstrate ATP consumption (B; red), followed by FCCP treatment to uncouple the mitochondria and demonstrate maximal respiratory capacity (C; green). Rotenone treatment to completely inhibit complex I is then used to reduce OCR to non-mitochondrial respiration only (D; yellow). For ECAR (right), a preliminary dose of glucose is used to stimulate extracellular acidification through glycolysis (A; blue), followed by oligomycin treatment to again inhibit ATP synthase and yield maximal glycolytic capacity (B; green). 2-DG is finally used as a glucose analog to competitively inhibit glycolysis and return ECAR to non-glycolytic acidification levels (C; yellow). In our studies, both OCR and ECAR were assessed simultaneously through four treatment points using oligomycin, FCCP, 2-DG, and rotenone in sequence (see Fig. 2). Maximal respiratory and/or glycolytic capacities were assessed using the same rationale following FCCP or oligomycin treatment, respectively. (PDF 119 kb)